Filing Details
- Accession Number:
- 0000899243-19-013056
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-10 16:39:21
- Reporting Period:
- 2019-05-08
- Accepted Time:
- 2019-05-10 16:39:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seattle Genetics Inc | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1167496 | B Clay Siegall | 21823 30Th Drive Se Bothell WA 98021 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-08 | 300 | $12.16 | 749,469 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-05-08 | 300 | $68.91 | 749,169 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-05-08 | 13,431 | $12.16 | 762,600 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-05-08 | 13,431 | $68.35 | 749,169 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-05-08 | 1,593 | $12.16 | 750,762 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-05-08 | 1,593 | $67.41 | 749,169 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-05-09 | 2,894 | $12.16 | 752,063 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-05-09 | 2,894 | $67.77 | 749,169 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-05-09 | 1,930 | $12.16 | 751,099 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-05-09 | 1,930 | $66.93 | 749,169 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-05-08 | 300 | $0.00 | 300 | $12.16 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-05-08 | 13,431 | $0.00 | 13,431 | $12.16 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-05-08 | 1,593 | $0.00 | 1,593 | $12.16 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-05-09 | 2,894 | $0.00 | 2,894 | $12.16 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-05-09 | 1,930 | $0.00 | 1,930 | $12.16 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 80,293 | 2019-08-25 | No | 4 | M | Direct | |
| 66,862 | 2019-08-25 | No | 4 | M | Direct | |
| 65,269 | 2019-08-25 | No | 4 | M | Direct | |
| 62,375 | 2019-08-25 | No | 4 | M | Direct | |
| 60,445 | 2019-08-25 | No | 4 | M | Direct |
Footnotes
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $68.90 to $68.91. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $67.89 to $68.78. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $66.89 to $67.88. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $67.41 to $68.14. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $66.35 to $67.33. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Options vested at a rate of 25% on 8/25/10 and monthly thereafter until all the options were fully vested on 8/25/13.
Billionaire Hedge Funds
